Healthcare Pharmaceutical Biotech

Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114

April 23, 2026 8:15 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company pioneering first-in-class neuropeptide therapies for stress-related neuropsychiatric disorders, today announced the appointment of Bill Nichols Jr. as President. This strategic leadership addition, combined with a thoughtful optimization of the Company's management structure, sharpens focus and resources on advancing its lead candidate, PT00114 - positioning...

Read more

Manatee Appoints Dr. Neha Chaudhary, Harvard Child Psychiatrist and Pioneer in Digital Mental Health, to Board of Directors

April 23, 2026 8:00 AM

Manatee, a virtual provider of structured, whole-family mental health care, today announced the appointment of Neha Chaudhary, MD, as an Independent Director to its Board of Directors. Dr. Chaudhary is a double board-certified child and adolescent psychiatrist on faculty at Harvard Medical School and Massachusetts General Hospital, co-founder of Brainstorm, Stanford's Lab for Mental Health Innovation, and currently Chief Medical Officer at...

Read more

2026 State of Digital Healthcare in Oncology Report Reveals Cancer Programs Are Rewiring Buying Around Speed to Treatment, Infusion Economics, and Precision Workflow - Black Book

April 23, 2026 7:15 AM

Black Book Research today announced the release of its new 2026 State of Digital Healthcare in Oncology Centers of Excellence, Chemotherapy and Infusion Networks, and Cancer Centers, a comprehensive market intelligence report examining how U.S. cancer programs are redesigning digital strategy across access, authorization, infusion, specialty pharmacy, pathology, genomics, navigation, analytics, research, and reimbursement. The report is based on...

Read more

Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion

April 23, 2026 7:00 AM

Sisel International today announced that it has appointed Pamela Ferry as General Manager of Australia and New Zealand as the company accelerates its expansion and transitions to full market operations across the region. Ferry brings more than 20 years of experience in the global direct selling industry, with a focus on international market expansion, distributor growth, and leadership development, including experience supporting the relaunch of...

Read more

Dosell Awarded Contract with Västervik Municipality Regarding Medication Dispensing Devices

April 23, 2026 2:50 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB, together with Atea Sverige AB, has been awarded a contract with Västervik Municipality and cooperating municipalities regarding the supply of medication dispensing devices. The award relates to tender area Group B, simple medication dispensing device, where Dosell is offered as a solution for medication management within municipal healthcare and social...

Read more

RhythmONE Reviewed: Is This Brain Supplement Legit? (Ingredients, Pricing, Benefits, and Side Effects)

April 22, 2026 6:35 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing. Supplements are not intended to diagnose, treat, cure, or prevent any disease. This article contains affiliate links. If you purchase through these links, a...

Read more

Gala GLP-1 2026: $179/mo Compounded Tirzepatide - Pricing Reality, Refund Policy Details, and What to Verify Before You Commit

April 22, 2026 6:30 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Prescription GLP-1 treatment is available only if a licensed provider independently determines it is medically appropriate for you. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you enroll through these links, a commission may be earned at no additional cost...

Read more

TridentCare Partners with ServiceNow to Power AI-Driven Transformation Across Operations

April 22, 2026 5:30 PM

TridentCare, the nation's leading provider of portable diagnostic services, today announced a strategic partnership with ServiceNow, the AI control tower for business reinvention, to transform how the company manages its end-to-end operations - from the moment a customer places an order through diagnostic delivery, results reporting, and reimbursement. The partnership builds on TridentCare's successful deployment of ServiceNow Field Service...

Read more

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

April 22, 2026 4:10 PM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results from the HOPE-at-Heart clinical trial (NCT06485596) were presented at the ISHLT Annual Meeting in Toronto. This prospective, multicenter trial, is the first to evaluate direct procurement of donor hearts after circulatory death (DCD) followed by preservation using HOPE with the XVIVO Heart Assist Transport. The trial successfully met its pre-specified primary endpoint....

Read more

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

April 22, 2026 4:10 PM

Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026. The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the...

Read more

Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto

April 22, 2026 3:55 PM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, preliminary one-year follow-up data from the US PRESERVE trial of XVIVO's investigational heart technology, ‘PRESERVE: A Prospective, Multi-center, Single-arm, Open-label Study,' were presented by the trial's principal investigator, Dr. Victor Pretorius, at the annual ISHLT conference in Toronto, Canada. The PRESERVE trial was designed to assess pre-specified safety and effectiveness...

Read more

ALL EYES ON CMS: Federal Fight Could Decide Whether Unapproved Cannabinoids Reach America's Seniors

April 22, 2026 2:45 PM

MMJ International Holdings today strongly rejected arguments by federal regulators that plaintiffs lack standing to challenge the Centers for Medicare & Medicaid Services' cannabinoid-access framework for hemp derived products. The government's assertion that participation by a pharmaceutical cannabinoid developer does not strengthen the case misunderstands both the structure of federal drug regulation and the real world impact of CMS policy...

Read more

Compassion Center, the National Coalition for Patient Rights and Stormy Ray Cardholders Foundation Launch National De-Schedule.org Campaign to Defend Patient and Private-Citizen Rights

April 22, 2026 1:00 PM

Compassion Center, the National Coalition for Patient Rights, or CPR, and the Stormy Ray Cardholders Foundation, or SRCF, today announced the official launch of a national awareness campaign through www.De-Schedule.org, calling on medical cannabis patients, caregivers, advocates and private citizens alike to stand up and support CPR's National De-Schedule campaign efforts and CPR's petition to defend patient access, improve civil liberties and...

Read more

Becker Aesthetics & Plastic Surgery Welcomes Dr. David W. Allison to Its Growing Team of Experts

April 22, 2026 12:00 PM

Becker Aesthetics & Plastic Surgery, a physician-led plastic surgery and aesthetics clinic known for its commitment to anatomy-driven care and natural outcomes, is pleased to announce the addition of Dr. David W. Allison to its team of board-certified surgeons. Dr. Allison is a board-certified plastic surgeon with more than 20 years of experience specializing in breast and body surgery, and his arrival marks a significant expansion of the...

Read more

CassianRx Launches ONE Journey(TM) to End Fragmentation Across the Specialty Pharmacy Ecosystem

April 22, 2026 11:00 AM

CassianRx, a healthcare technology company focused on workflow automation, patient engagement, and data infrastructure for specialty pharmacy, today announced the launch of ONE Journey™ (Optimized Network for Engagement). The platform sits above existing pharmacy management systems to connect patients, providers, specialty pharmacies, pharmaceutical manufacturers, and payers in one coordinated ecosystem. ONE Journey™ supports thousands of...

Read more

Efferon Receives CE MDR Mark for Efferon NEO, Europe's First Multimodal Extracorporeal Blood Purification Device for Pediatric Use

April 22, 2026 11:00 AM

Efferon, a biotech company manufacturing multimodal hemoadsorption therapeutic devices designed to remove endotoxins and inflammatory mediators directly from the bloodstream, announces receipt of the CE MDR mark for Efferon NEO, making it Europe's first hemoadsorption device approved for use in neonatal and pediatric patients with sepsis and septic shock. The certification is supported by results of the multicenter LASSO NEO study (NCT05707494),...

Read more

Joint Commission-Accredited Urgent Care Expands in Surfside, Adding Concierge Medicine, IV Therapy, and Hyperbaric Oxygen Therapy

April 22, 2026 10:50 AM

TrufaMED Urgent Care & Concierge Medicine, the only Joint Commission-accredited urgent care clinic in Florida and among a limited number nationwide, today announced the expansion of its clinical service menu at its Surfside, Florida flagship. The new services include urgent care walk-in services, on-site laboratory, X-ray imaging, pediatric and adult care, three-tier concierge medicine memberships, a full IV therapy program, hyperbaric oxygen...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Continues Revenue Pipeline as Infinite Auctions Accepts Consignments for Next Auction

April 22, 2026 9:11 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) is pleased to announce that its subsidiary, Infinite Auctions, is now accepting consignments for its upcoming sports memorabilia auction. Collectors, investors, and enthusiasts are invited to submit high-end sports memorabilia, sports cards, and autographed items for inclusion in what is expected to be another highly anticipated auction event. Infinite Auctions continues to establish itself as a...

Read more

Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00

April 22, 2026 9:00 AM

Emerging Growth Research today released a Flash Report on Immuron (Nasdaq:IMRN), maintaining its Buy-Extended rating while increasing its 12-month price target to $4.00 (from $3.90), representing significant upside from the current share price of $0.9268 as of April 21, 2026. The Flash Report highlights Immuron's continued revenue growth, expanding commercial footprint, and progress within its clinical development pipeline. Key Highlights:...

Read more

Coram CVS Specialty Infusion Services Uses New Sustainable Packaging

April 22, 2026 9:00 AM

Key points Coram CVS Specialty Infusion Services transitioned to recyclable, compostable packaging for temperature-sensitive medications - replacing bulky legacy packaging with wood and paper-based insulation. The new innovative packaging is easier to handle, more compact, and designed to improve the patient experience, especially for those with mobility challenges. This change supports our enterprise-wide sustainability objectives while...

Read more